Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
August Equity funds management buyout of pet imaging firm

August Equity has funded the management buyout of Hallmarq Veterinary Imaging, a global specialist in MRI imaging for horses and companion animals.

The deal, led by partner Garret Turley working with Kate Cook and Kishan Chotai, marks the seventh investment made from the private equity house’s latest fund, August Equity Partners IV. The fund, which was raised in April 2017, is now 55% deployed.

The support of the Hallmarq buyout was made in the context of a growing market for sophisticated diagnostic techniques in veterinary practice. Founded in 2001, Hallmarq has developed the world’s only MRI scanner for the standing horse and PetVet, an MRI system specifically designed for the anatomy of dogs and cats, replacing the use of refurbished human machines.

“We strongly believe that Hallmarq is uniquely placed to satisfy the growing global demand for top-quality animal healthcare diagnostic services and we’re excited to help them achieve their international aims,” said Turley.

Hallmarq chief executive Jos Belgrave added: “Our next steps are to expand our presence in the US market and to focus further on the PetVet system to ensure that vets worldwide have access to the most effective diagnostic technology. We look forward to working together with August Equity to achieve that.”

Posted on: 13/12/2018

Latest news stories

22/03/2019
A report by the National Audit Office has raised concerns over the lack of capacity in the NHS and resulting increase in waiting times for patients.
22/03/2019
Civitas Social Housing has acquired properties worth £85.6 million.
22/03/2019
VPS Healthcare, an Abu Dhabi-based hospital operator, is reconsidering plans to list on London Stock Exchange due to uncertainty surrounding Britain’s EU exit.
21/03/2019
The UK’s largest private healthcare provider is closing two of its hospitals and selling a third to the NHS.
21/03/2019
Healthcare software provider EMIS Group has reported growth in turnover and operating profit in its final results for the year ended 31 December 2018.


Civica


HealthInvestor blog
The chaos around the UK leaving the EU continues apace but healthcare investment is steering a steady course through the storm

Click here to view the HealthInvestor blog


A manufacturing aficionado intrigued by the possibilities tech offers to revolutionise health delivery and positively impact lives
abc ivf is offering IVF treatment at prices well below the industry average, suggesting it may have developed a winning formula – but are they cutting corners or is everyone else missing a trick, and what could it mean for the IVF sector and patients in future? Jeremy Bowden investigates
Where are the opportunities in care homes and retirement living? Carterwood’s director Tom Hartley and principal analyst Aishling Barrett analyse the sector’s supply and demand
Private equity interest in medical devices is growing. Catherine Gooderham takes a look at this complex and diverse market
The UK independent hospital sector has suffered considerable reputational damage in recent years. With falling NHS referrals and criticism from both the regulator and the government, Rob Munro looks at what changes are afoot to deal with a crisis of confidence in a market worth over £5 billion

Click here to search all feature articles



The private hospital sector

The UK independent hospital sector has suffered considerable reputational damage in recent years. With falling NHS referrals and criticism from both the regulator and the government, Rob Munro looks at what changes are afoot to deal with a crisis of confidence in a market worth over £5 billion
Read more


Christie + Co

my images



Company profile: Montreux Capital Management

The healthcare sector continues to evolve and it's the innovators that will shape its future. Marie Cahalane caught up with Oliver Harris, founder and chief executive of Montreux Capital Management, and quizzed him about his company's active approach to investment
Read more